Therole of 55 kDa and 75 kDa TNF receptor in sigraling of humen neutrophil
55 kDa和75 kDa TNF受体在人中性粒细胞信号传导中的作用
基本信息
- 批准号:06671210
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The expression and biological role of 55- and 75-kDa tumor necrosis factor-receptors (TNF-R) in human polymorphonuclear cells (PMN) in vitro were studied using agonistic rabbit polyclonal anti-TNF-R antibodies. PMN express 75-kDa TNF-R predominantly according to flow cytometric analysis and a ^<125>I-LT binding assay. PMN produce and release the superoxide anion on stimulation by human recombinant lymphotoxin (LT) in vitro. Anti-55- but not anti-75-kDa TNF-R antibody stimulated the superoxide release mimicking LT.Release of the elastase from azurophilic granule of PMN was augmented by LT in vitro. Anti-55- but not anti-75-kDa TNF-R antibody augmented the clastase release mimicking LT.Release of the lactoferrin from the specific granules of PMN was enhanced by LT in vitro. Anti-55- but not anti-75-kDa TNF-R antibody enhanced the laccoferrin release. These antibodies failed to co-stimulate these PMN functions. The peak adhesiveness of PMN to a plastic plate and the peak expression of Mac-1 adhesion molecule (CD11b/CD18) on PMN were upregulated by LT in vitro. Anti-55- but not anti-75-kDa TNF-R antibody upregulated the peak adhesiveness of PMN and CD11b/CD18 expression mimicking LT.Though anti-75-kDa TNF-R antibody by itself did not alter the adhesiveness and marginally suppressed Mac-1 expression of PMN,it maintained the adhesiveness and adhesion molecule expression in the presence of anti-55-kDa TNF-R antibody. In summary, PMN predominantly express 75-kDa TNF-R,the signaling of LT (and TNF) in PMN is mediated mainly by 55-kDa TNF-R,and the adhesion function can be modulated also by 75-kDa TNF-R when 55-kDa TNF-R is stimulated.
用兔抗肿瘤坏死因子受体(TNF-R)多克隆抗体研究了体外培养的人中性粒细胞(PMN)55和75 kDa TNF-R的表达及其生物学作用。根据流式细胞术分析和γ I-LT结合试验,PMN主要表达75-kDa TNF-R<125>。在体外,PMN在人重组光敏素(LT)刺激下产生并释放超氧阴离子。抗-55-而不是抗-75-kDa TNF-R抗体刺激超氧化物释放模仿LT。释放的弹性蛋白酶从嗜天青颗粒的PMN在体外增强LT。抗-55-但不是抗-75-kDa TNF-R抗体增强了模拟LT的断裂酶释放。在体外,LT增强了从PMN特定颗粒释放乳铁蛋白。抗-55-但不是抗-75-kDa的TNF-R抗体增强了乳铁蛋白的释放。这些抗体未能共同刺激这些PMN功能。LT可上调PMN粘附分子Mac-1(CD 11b/CD 18)的表达。抗55 kDa TNF-R抗体可上调PMN的最大粘附率和CD 11b/CD 18的表达,但抗75 kDa TNF-R抗体本身并不改变PMN的最大粘附率,并略微抑制其Mac-1的表达,但在抗55 kDa TNF-R抗体存在下,可维持PMN的粘附分子和粘附分子的表达。总之,PMN主要表达75-kDa TNF-R,PMN中LT(和TNF)的信号传导主要由55-kDa TNF-R介导,并且当55-kDa TNF-R被刺激时,粘附功能也可由75-kDa TNF-R调节。
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y Abe, Y Kashu et al.: "Idatification and biochemical characterization of human plasna neutrophil inhibitor in vitro." Surgery. 25. 139-144 (1995)
Y Abe、Y Kashu 等人:“人血浆中性粒细胞抑制剂的体外鉴定和生化特征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y Abe, Y Osuka et al.: "The funtional role of 55- and 75-kDa tumor recrosis factor receptors in human polymorphonuclear cells in vitro." Cytokine. 7. 39-49 (1995)
Y Abe、Y Osuka 等人:“55-和 75-kDa 肿瘤坏死因子受体在体外人多形核细胞中的功能作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yashuhito Abe et al: "The functional role of 55-and 75-kDa tumor necrosis factor receptors in human polymophonuclear cells inv" Cytokine. (in press).
Yashuhito Abe 等人:“55-和 75-kDa 肿瘤坏死因子受体在人多形核细胞中的功能作用”细胞因子。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y Abe,Y Kashu et al.: "Iden tification and biochemical choracterigation of human plasma neutrophil inhibitor in vitro." Surgery Today. 25. 139-144 (1995)
Y Abe,Y Kashu 等人:“人血浆中性粒细胞抑制剂的体外鉴定和生化鉴定”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yashuhito Abe et al.: "Plasma neutrophhil inhibitor(PNI):Identification and biochemical characterization" Surgery Today. (in press).
Yashuhito Abe 等人:“血浆中性粒细胞抑制剂(PNI):鉴定和生化特征”《今日外科》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OSUKA Yo其他文献
OSUKA Yo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
新規Lymphotoxin発現細胞による胸腺髄質成熟機構の解明
使用新型淋巴毒素表达细胞阐明胸腺髓质成熟机制
- 批准号:
24K18471 - 财政年份:2024
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
LTBR CARs as next-generation therapies for R/R lymphoma
LTBR CAR 作为 R/R 淋巴瘤的下一代疗法
- 批准号:
10635791 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Diversity supplement: Lymphatic regulation of lymph node function in lupus
多样性补充:狼疮淋巴结功能的淋巴调节
- 批准号:
10794867 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
The role of lymph node structural organization in naïve T cell decline with age
淋巴结结构组织在幼稚 T 细胞随年龄下降中的作用
- 批准号:
10730844 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
In vivo inflammatory challenge to elucidate the role of the toll-like receptor 4 pathway in depression
体内炎症挑战阐明 Toll 样受体 4 通路在抑郁症中的作用
- 批准号:
10448689 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Enhancement of Human Immune System Development in Mouse Models
增强小鼠模型中的人类免疫系统发育
- 批准号:
10548100 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Targeting SARS-CoV-2 induced lung immunopathology using novel genetic mouse models
使用新型基因小鼠模型针对 SARS-CoV-2 诱导的肺部免疫病理学
- 批准号:
10619617 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary Fibrosis
一种治疗特发性肺纤维化的新型双特异性抗体
- 批准号:
10594937 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression
基质微环境作为膀胱癌发生和进展的共同组织者
- 批准号:
10519080 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Targeting SARS-CoV-2 induced lung immunopathology using novel genetic mouse models
使用新型基因小鼠模型针对 SARS-CoV-2 诱导的肺部免疫病理学
- 批准号:
10453265 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:














{{item.name}}会员




